These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29599181)

  • 41. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H
    World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis.
    Sanduleanu S; Jonkers D; De Bruïne A; Hameeteman W; Stockbrügger RW
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1163-75. PubMed ID: 11472319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
    Rauws EA
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis: the influence of pre-treatment with a proton pump inhibitor on Helicobacter pylori eradication.
    Janssen MJ; Laheij RJ; de Boer WA; Jansen JB
    Aliment Pharmacol Ther; 2005 Feb; 21(4):341-5. PubMed ID: 15709984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Review Article: is Helicobacter pylori relevant in the management of reflux disease?
    Dent J
    Aliment Pharmacol Ther; 2001 Jun; 15 Suppl 1():16-21. PubMed ID: 11488657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for gastric cancer: is it time to discard PPIs?
    Laterza L; Scaldaferri F; Gasbarrini A
    Gut; 2019 Jan; 68(1):176-177. PubMed ID: 29331945
    [No Abstract]   [Full Text] [Related]  

  • 48. Proton pump inhibitors, enterochromaffin-like cell growth and Helicobacter pylori gastritis.
    Solcia E; Villani L; Luinetti O; Fiocca R
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():25-8, discussion 29-31. PubMed ID: 8490076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
    Shimizu N; Kubota K; Kaminishi M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():478-81. PubMed ID: 16363583
    [No Abstract]   [Full Text] [Related]  

  • 50. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication.
    Tan AC; Hartog GD; Mulder CJ
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1519-22. PubMed ID: 10571610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eradication of Helicobacter pylori infection.
    Hunt RH
    Am J Med; 1996 May; 100(5A):42S-50S; discussion 50S-51S. PubMed ID: 8644782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton pump inhibitors and gastric neoplasia.
    Kuipers EJ
    Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study: Vonoprazan and proton pump inhibitors in
    Sakurai K; Suda H; Ido Y; Takeichi T; Okuda A; Hasuda K; Hattori M
    World J Gastroenterol; 2017 Jan; 23(4):668-675. PubMed ID: 28216974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
    Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
    Ohkusa T; Takashimizu I; Fujiki K; Suzuki S; Shimoi K; Horiuchi T; Sakurazawa T; Ariake K; Ishii K; Kumagai J; Tanizawa T
    Ann Intern Med; 1998 Nov; 129(9):712-5. PubMed ID: 9841603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Helicobacter pylori: reasons for eradication].
    Schuster M
    Praxis (Bern 1994); 2004 Dec; 93(51-52):2135-41. PubMed ID: 15672764
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
    Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
    Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of CYP2C19 functional polymorphism on Helicobacter pylori eradication.
    Ozdil B; Akkiz H; Bayram S; Bekar A; Akgöllü E; Sandikçi M
    Turk J Gastroenterol; 2010 Mar; 21(1):23-8. PubMed ID: 20533108
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
    Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.